The growing geriatric population, rapid technological advancements, increasing number of aesthetic procedures worldwide, and rising awareness about advanced aesthetic treatments are the major factors responsible for the growth of the global facial skin ablative treatment market. Due to the aforementioned factors, the market is projected to grow at a CAGR of 7.8% during 2020–2030, to reach $8,394.3 million by 2030.
Due to the ongoing COVID-19 pandemic, the global facial skin ablative treatment market has been negatively impacted. This is due to the shortage of employees, lockdowns, and disruption of supply chains. Thus, the trade of facial skin ablative treatment products has been affected as a consequence of the reduced demand, constraints in handling and transporting goods, and closure of manufacturing facilities.
Based on technology, the facial skin ablative treatment market is categorized into laser skin resurfacing, radiofrequency (RF) microneedling, dermal fillers, and mesotherapy. Among them, the RF microneedling category is expected to witness the fastest growth during the forecast period, due to the ability of this skin-tightening technology to reduce fine lines and wrinkles, especially around the eyes, mouth, and cheeks, better than others. Further, it helps in reducing pores, acne scars, and stretch marks, while minimizing the downtime.
Based on application, the facial skin ablative treatment market is categorized into aging, acne and other scars, hyperpigmentation, wrinkles, and others. Among these, the acne and other scars category dominated the market in 2019, majorly due to the rapid adoption of a sedentary lifestyle which triggers hormonal changes, imbalanced diet, and stress, which resulted in the rising incidence of acne in both men and women across the world.
Geographically, North America held the largest share in the facial skin ablative treatment market in 2019, and the same situation is predicted for the forecast period. The is attributed to the high prevalence of skin conditions, including facial skin problems, strong presence and a diverse product portfolio of key market players, high awareness regarding advanced technologies, and rising concerns among people over their physical appearance.
Players in the global facial skin ablative treatment market are actively involved in product launches to gain a competitive edge. For instance, in November 2020, Crown Aesthetics, a division of Crown Laboratories Inc., announced the receipt of the Class IIa CE Certification mark by SkinPen Precision. The certification confirms that the product can be used to improve the appearance of facial acne scars on people aged 22 years and more and reduce the appearance of fine lines and wrinkles on the face and neck. The product can also treat pigmentation conditions (dyschromia), including melasma, vitiligo, and solar lentigines.
Similarly, in April 2019, Lumenis Ltd. launched the Legend Pro+ face and body platform. It offers a comprehensive solution with immediate results, long-term efficacy, minimal pain and downtime, and no need for anesthesia.
Some of the major players operating in the global facial skin ablative treatment market are Alma Lasers Ltd., Hologic Inc., Imdad LLC, Cutera Inc., Crown Laboratories Inc., Syneron Medical Ltd., Sciton Inc., Fotona D.o.o., EL.EN. S.p.A., and Stryker Corporation.